AIM2 and gastric cancer: We also discovered that the p-p38, p-JNK, and p-ERK levels were reduced in sh-AIM2 tumors relative to controls (Figure 5(d)), suggesting that AIM2 knockdown may inhibit excessive MAPK signaling in GC tumors, thereby constraining their growth.